2023 - Research.com Medicine in Finland Leader Award
Internal medicine, Endocrinology, Diabetes mellitus, Metabolic syndrome and Type 2 diabetes are his primary areas of study. Leo Niskanen works mostly in the field of Internal medicine, limiting it down to topics relating to Surgery and, in certain cases, Incidence, as a part of the same area of interest. His Endocrinology research is multidisciplinary, incorporating elements of Prospective cohort study, Antibody, Cause of death and Confidence interval.
His research in Diabetes mellitus intersects with topics in Physical fitness, Physical exercise and Vascular disease. The concepts of his Metabolic syndrome study are interwoven with issues in Body mass index, Sex hormone-binding globulin, Cohort study and Testosterone. His study explores the link between Type 2 diabetes and topics such as Weight loss that cross with problems in Tolerability, Liraglutide and Impaired fasting glucose.
His primary scientific interests are in Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin. His study connects Surgery and Internal medicine. His research in Insulin resistance, Cholesterol, Obesity, Glucose tolerance test and Weight loss are components of Endocrinology.
The study incorporates disciplines such as Cohort study, Cohort and Population study in addition to Diabetes mellitus. His Population study research incorporates themes from Statin and Medical prescription. Specifically, his work in Metabolic syndrome is concerned with the study of National Cholesterol Education Program.
Leo Niskanen focuses on Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Population study. In general Internal medicine, his work in Body mass index, Insulin and Metabolic syndrome is often linked to Intima-media thickness linking many areas of study. The various areas that he examines in his Metabolic syndrome study include Calcium and Insulin resistance.
His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Blood pressure, Cohort study, Cohort and Intensive care medicine. His Type 2 diabetes study integrates concerns from other disciplines, such as Metformin, Obesity, Gerontology, Lifestyle intervention and Family medicine. His biological study deals with issues like Hormone replacement therapy, which deal with fields such as Testosterone.
His scientific interests lie mostly in Type 2 diabetes, Internal medicine, Diabetes mellitus, Insulin and Endocrinology. His Type 2 diabetes research is multidisciplinary, incorporating perspectives in Metformin, Gerontology, Public health and Confidence interval. His studies in Internal medicine integrate themes in fields like Diabetic nephropathy, Nephropathy and Population study.
His studies deal with areas such as Secondary care, Primary care, Physical health and MEDLINE as well as Diabetes mellitus. In his work, Cholecystokinin, Appetite, Polyunsaturated fat and Finnish population is strongly intertwined with Food science, which is a subfield of Insulin. Leo Niskanen studies Endocrinology, namely Metabolic syndrome.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
THE METABOLIC SYNDROME AND TOTAL AND CARDIOVASCULAR DISEASE MORTALITY IN MIDDLE-AGED MEN
Hanna-Maaria Lakka;David E. Laaksonen;Timo A. Lakka;Leo K. Niskanen.
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Lennart Hansson;Lars H Lindholm;Leo Niskanen;Jan Lanke.
The Lancet (1999)
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).
Jari Tiihonen;Jari Tiihonen;Jouko Lönnqvist;Kristian Wahlbeck;Timo Klaukka.
The Lancet (2009)
Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.
David E. Laaksonen;Hanna-Maaria Lakka;Leo K. Niskanen;George A. Kaplan.
American Journal of Epidemiology (2002)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Arne Astrup;Stephan Rössner;Luc Van Gaal;Aila Rissanen.
The Lancet (2009)
Testosterone and Sex Hormone–Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men
David E. Laaksonen;Leo Niskanen;Kari Punnonen;Kristiina Nyyssönen.
Diabetes Care (2004)
Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-Aged Men: A Prospective Cohort Study
Leo K. Niskanen;David E. Laaksonen;Kristiina Nyyssönen;Georg Alfthan.
JAMA Internal Medicine (2004)
Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.
David E. Laaksonen;Hanna-Maaria Lakka;Jukka T. Salonen;Leo K. Niskanen.
Diabetes Care (2002)
Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus.
Juhani Partanen;Leo Niskanen;Juha Lehtinen;Esa Mervaala.
The New England Journal of Medicine (1995)
Physical Activity in the Prevention of Type 2 Diabetes The Finnish Diabetes Prevention Study
David E. Laaksonen;Jaana Lindström;Timo A. Lakka;Johan G. Eriksson.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: